产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF7068, RRID:AB_2839024.
展开/折叠
Adenylate cyclase stimulating G alpha protein; AHO; C20orf45; Extra large alphas protein; GNAS complex locus; GNAS1; GPSA; GSA; GSP; Guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1; Guanine nucleotide binding protein G(s) alpha subunit; Guanine nucleotide binding protein G(s) subunit alpha isoforms XLas; guanine nucleotide regulatory protein; NESP; Neuroendocrine secretory protein; PHP1A; PHP1B; PHP1C; POH; RP4-543J19.4; Secretogranin VI; XLalphas;
抗原和靶标
A synthesized peptide derived from human GNAS, corresponding to a region within N-terminal amino acids.
- P63092 GNAS2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MGCLGNSKTEDQRNEEKAQREANKKIEKQLQKDKQVYRATHRLLLLGAGESGKSTIVKQMRILHVNGFNGEGGEEDPQAARSNSDGEKATKVQDIKNNLKEAIETIVAAMSNLVPPVELANPENQFRVDYILSVMNVPDFDFPPEFYEHAKALWEDEGVRACYERSNEYQLIDCAQYFLDKIDVIKQADYVPSDQDLLRCRVLTSGIFETKFQVDKVNFHMFDVGGQRDERRKWIQCFNDVTAIIFVVASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFLNKQDLLAEKVLAGKSKIEDYFPEFARYTTPEDATPEPGEDPRVTRAKYFIRDEFLRISTASGDGRHYCYPHFTCAVDTENIRRVFNDCRDIIQRMHLRQYELL
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - P63092 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K8 | Ubiquitination | Uniprot | |
K17 | Ubiquitination | Uniprot | |
K28 | Ubiquitination | Uniprot | |
K32 | Ubiquitination | Uniprot | |
S51 | Phosphorylation | Uniprot | |
K53 | Ubiquitination | Uniprot | |
K58 | Ubiquitination | Uniprot | |
K88 | Ubiquitination | Uniprot | |
K91 | Ubiquitination | Uniprot | |
K96 | Ubiquitination | Uniprot | |
K100 | Ubiquitination | Uniprot | |
Y177 | Phosphorylation | Uniprot | |
K181 | Ubiquitination | Uniprot | |
K186 | Ubiquitination | Uniprot | |
Y190 | Phosphorylation | Uniprot | |
S193 | Phosphorylation | Uniprot | |
T204 | Phosphorylation | Uniprot | |
T210 | Phosphorylation | Uniprot | |
K211 | Ubiquitination | Uniprot | |
K216 | Ubiquitination | Uniprot | |
K274 | Ubiquitination | Uniprot | |
K293 | Ubiquitination | Uniprot | |
K300 | Ubiquitination | Uniprot | |
K305 | Ubiquitination | Uniprot | |
K307 | Ubiquitination | Uniprot | |
Y311 | Phosphorylation | Uniprot | |
T335 | Phosphorylation | Uniprot | |
K338 | Ubiquitination | Uniprot | |
R347 | Methylation | Uniprot | |
S352 | Phosphorylation | Uniprot | |
Y358 | Phosphorylation | Uniprot | |
Y360 | Phosphorylation | Uniprot | |
Y391 | Phosphorylation | Uniprot |
研究背景
Guanine nucleotide-binding proteins (G proteins) function as transducers in numerous signaling pathways controlled by G protein-coupled receptors (GPCRs). Signaling involves the activation of adenylyl cyclases, resulting in increased levels of the signaling molecule cAMP. GNAS functions downstream of several GPCRs, including beta-adrenergic receptors. Stimulates the Ras signaling pathway via RAPGEF2.
Cell membrane>Lipid-anchor.
Heterotrimeric G proteins are composed of 3 units; alpha, beta and gamma. The alpha chain contains the guanine nucleotide binding site. Interacts with CRY1; the interaction may block GPCR-mediated regulation of cAMP concentrations. Interacts with ADCY5 and stimulates its adenylyl cyclase activity. Interacts with ADCY6 and stimulates its adenylyl cyclase activity. Interacts with ADCY2 (By similarity). Interaction with SASH1. Interacts with GAS2L2.
Belongs to the G-alpha family. G(s) subfamily.
研究领域
· Cellular Processes > Cellular community - eukaryotes > Gap junction. (View pathway)
· Environmental Information Processing > Signal transduction > Rap1 signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Calcium signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > cAMP signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Phospholipase D signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > Endocrine resistance.
· Human Diseases > Substance dependence > Cocaine addiction.
· Human Diseases > Substance dependence > Amphetamine addiction.
· Human Diseases > Substance dependence > Morphine addiction.
· Human Diseases > Substance dependence > Alcoholism.
· Human Diseases > Infectious diseases: Bacterial > Vibrio cholerae infection.
· Human Diseases > Infectious diseases: Parasitic > Chagas disease (American trypanosomiasis).
· Human Diseases > Infectious diseases: Parasitic > Amoebiasis.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cardiovascular diseases > Dilated cardiomyopathy (DCM).
· Organismal Systems > Circulatory system > Adrenergic signaling in cardiomyocytes. (View pathway)
· Organismal Systems > Circulatory system > Vascular smooth muscle contraction. (View pathway)
· Organismal Systems > Immune system > Platelet activation. (View pathway)
· Organismal Systems > Environmental adaptation > Circadian entrainment.
· Organismal Systems > Nervous system > Glutamatergic synapse.
· Organismal Systems > Nervous system > Serotonergic synapse.
· Organismal Systems > Nervous system > Dopaminergic synapse.
· Organismal Systems > Nervous system > Long-term depression.
· Organismal Systems > Sensory system > Inflammatory mediator regulation of TRP channels. (View pathway)
· Organismal Systems > Endocrine system > Insulin secretion. (View pathway)
· Organismal Systems > Endocrine system > Ovarian steroidogenesis.
· Organismal Systems > Endocrine system > Estrogen signaling pathway. (View pathway)
· Organismal Systems > Endocrine system > Melanogenesis.
· Organismal Systems > Endocrine system > Thyroid hormone synthesis.
· Organismal Systems > Endocrine system > Oxytocin signaling pathway.
· Organismal Systems > Endocrine system > Glucagon signaling pathway.
· Organismal Systems > Endocrine system > Regulation of lipolysis in adipocytes.
· Organismal Systems > Endocrine system > Renin secretion.
· Organismal Systems > Endocrine system > Aldosterone synthesis and secretion.
· Organismal Systems > Endocrine system > Relaxin signaling pathway.
· Organismal Systems > Excretory system > Endocrine and other factor-regulated calcium reabsorption.
· Organismal Systems > Excretory system > Vasopressin-regulated water reabsorption.
· Organismal Systems > Digestive system > Salivary secretion.
· Organismal Systems > Digestive system > Gastric acid secretion.
· Organismal Systems > Digestive system > Pancreatic secretion.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.